Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Reexamination Certificate
2007-04-03
2007-04-03
Saucier, Sandra E. (Department: 1651)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
C514S002600
Reexamination Certificate
active
10399223
ABSTRACT:
Reducing or preventing adhesions which would form in a patient during or after surgery by administering to the wound surface of a patient a fibrinogen solution in an amount of about 0.025 ml fibrinogen/cm2to about 0.25 ml fibrinogen/cm2of the surface being at risk for developing adhesions. User of fibrinogen in a preparation comprising fibrinogen at a concentration of 20 to 80 mg/ml for the reduction or prevention of post-surgical adhesion formation.
REFERENCES:
patent: 99/56797 (1999-11-01), None
Jahoda et al., “Fibrin sealant inhibits connective tissue deposition in a murine model of peritoneal adhesion formation”, Surgery 125 (1) : 53-59 (1999).
Lindenberg et al., “Prevention of peritoneal adhesion formation by fibrin sealant”, Annales Chirurgiae et Gynaecologiae 73 : 11-13 (1984).
Aliredjo et al., “The use of Gore-Tex membrane for adhesion prevention in tethered spinal cord surgery; Technical case reports”, Neurosurgery 44 (3) : 674-678 (1999). abstract only.
Redl Heinz
Simunek Manuela
Spaethe Reiner
Baxter Healthcare S.A.
Baxter International Inc.
Saucier Sandra E.
LandOfFree
Method for the reduction or prevention of post-surgical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the reduction or prevention of post-surgical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the reduction or prevention of post-surgical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3764340